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Overview of
workbook series
This workbook is part of a series in-
tended to educate programme planners,
managers, staff and other decision-mak-
ers about the evaluation of services and
systems for the treatment of psychoac-
tive substance use disorders. The objec-
tive of this series is to enhance their ca-
pacity for carrying out evaluation
activities. The broader goal of the work-
books is to enhance treatment efficiency
and cost-effectiveness using the informa-
tion that comes from these evaluation ac-
tivities.
This introductory workbook presents a frame-
work for conducting all types of treatment
evaluations. A “how to” foundation of evalu-
ations is presented, and different types of
specialised evaluation are described briefly.
Introductory Workbook
Framework Workbook
Foundation Workbooks
Workbook 1: Planning Evaluations
Workbook 2: Implementing Evaluations
Specialised Workbooks
Workbook 3: Needs Assessment Evaluations
Workbook 4: Process Evaluations
Workbook 5: Cost Evaluations
Workbook 6: Client Satisfaction Evaluations
Workbook 7: Outcome Evaluations
Workbook 8: Economic Evaluations
7Framework Workbook
WHO/MSD/MSB 00.2a
How to use
the workbooks
Effective learning happens when you use
new information in answering questions and
doing activities.
Throughout the workbooks, you will find
this symbol:
and the phrase It’s your turn.
When you see this symbol and phrase, it
means that there are questions for you to
answer, or an activity for you to do. These
exercises will help you to learn the material
better, so be sure to complete them with
your evaluation-planning group as you read
the workbooks.
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Introduction
Evaluation is an
attitude of continually
questioning and
gaining information.
Establishing a healthy
culture for evaluation
In this workbook series, you will learn many impor-
tant steps (or procedures) for doing evaluations in
your community. It is important to learn these proce-
dures because they will help you conduct better evalu-
ations.
It is important to realise, however, that treatment
evaluation is more than a set of procedures. Evalua-
tion is an attitude of continually questioning and gain-
ing information. Feedback
on all aspects of a
programme is obtained
and put to use, even if it is
less positive than antici-
pated.
A healthy culture for
evaluation (see figure) is
one in which feedback loops are woven into the fab-
ric of the treatment service or system. Some feed-
back loops serve the purpose of providing basic ac-
countability data to programme or system funders,
clients, and the general public. Other feedback loops
are better viewed as the means by which a programme
or treatment system seeks to continuously improve
its services and outcomes. One of the goals of this
workbook series is to enable you to establish a healthy
culture for evaluation within your own setting.
Initially, not everyone may want to engage in evalua-
tion. Indeed, many people involved with treatment
services and systems have an inherent fear of evalua-
tion. Managers and staff, for example, may be afraid
of evaluation because they feel it is they who may be
evaluated; they may be afraid for their jobs, their repu-
tations and their clients; or they may be afraid that
their programme or community network of
programmes will be reduced, abandoned, or modi-
fied in a way that is unacceptable to them. They also
may fear that they will have no control over the evalu-
ation process, the data
being collected and how
it will be used.
These fears are natural
and understandable, but
based frequently on mis-
information and/or a de-
sire to maintain the status
quo at all costs. In reality, treatment programmes are
rarely closed because of a single evaluation. More
frequently, some modifications to the existing struc-
ture may occur. However, it is still important to un-
derstand these fears, because people with these fears
can create significant impediments for conducting
evaluations. In these cases, full collaboration during
evaluation planning and implementation may be a use-
ful strategy. Over time, people usually see the ben-
efits of evaluation in terms of improved patient care
and cost savings. Fears are reduced, and opportu-
nity arises for a healthy culture for evaluation to be
firmly established.
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Who might support you in establishing a healthy culture for evaluation?
Who might not support you in establishing a healthy culture for evaluation?
Its your turn
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WHY
is treatment
• Treatment services are growing
• Despite scarcity, resources are given to ineffec-
tive treatments
• Treatment evaluation improves quality of care and
saves money for services that are effective
evaluation important?
The needs of the
overall population are
often not met as a
result of inefficient use
of scarce resources.
Large numbers of people suffer from psychoactive
substance use disorders1  and require treatment. De-
spite primary prevention and efforts to control the
supply of alcohol and other PS in the communities
around the world, the number of people entering treat-
ment continues to grow.
Historically, scientific re-
search and programme
evaluation have played a
minor role in determining
what treatments will be
funded or developed fur-
ther. Programme planners
and decision-makers tra-
ditionally have relied more
on personal experience
and opinions than on
evaluation data that is sys-
tematically gathered and analysed. This has led to dis-
parities in the development, and management of na-
tional and international treatment services. Consequently,
the needs of the overall population are often not met as a
result of inefficient use of scarce resources.
Most existing treatment approaches have not been
evaluated. Cost-effectiveness analyses are uncom-
mon. Reforms in the structure of health and social
care systems are underway in many nations, and scar-
city of resources available for treatment of PSU dis-
orders demands that the role of research and
programme evaluation become more prominent than
in the past.
Quality treatment should be made available, ac-
cessible and affordable to those in need. The de-
velopment of rational policies related to service pro-
vision is best achieved by conducting evaluations.
This generates information about the most efficient
ways to allocate available resources. Although
there are many chal-
lenges to conducting field
research and programme
evaluation in this area,
questions related to cost
and effectiveness can be
investigated.
There is an urgent need
to provide a practical
framework for evaluation
that can be adapted to
various countries and
cultural settings. This workbook series aims to
educate programme planners, managers and key
decision makers about the importance of
programme evaluation and its role in planning and
delivering treatment services and systems. In ful-
filling this objective, we hope to reduce barriers in
conducting programme evaluations and using the
results in the decision-making process.
1 There are many terms used internationally for “problems” related to substance use (e.g., drug addiction, alcoholism, dependence, abuse, misuse). We will use the
abbreviation PS to refer generally to psychoactive substances (including alcohol, nicotine/tobacco, cannabis, cocaine, opioids, etc), and the term PSU to refer generally
to psychoactive substance use. We will use the more general term psychoactive substance use disorders (or PSU disorders for short) to reflect the international standard
of ICD 10, thus encompassing substance use dependence, harmful use, and other conditions.
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List three ways that treatment evaluation would help treatment services in
your community.
Its your turn
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WHAT
is treatment?
The term treatment is used to define the process that begins
when psychoactive PS users come into contact with a health
provider or other community service, and may continue through
a succession of specific interventions until the highest attainable
level of health and well-being is reached.
a comprehensive approach to detection, assistance,
health care, and social integration of persons present-
ing problems caused by any PSU. “Treatment” also
can be defined in relation to the term “prevention,”
with the former aimed at reducing or eliminating prob-
lems related to PSU, and the latter intended to pre-
vent their occurrence in the first place. For the pur-
pose of this workbook series, brief interventions are
included within the definition of treatment.
Treatment evaluation as feedback
Because the intent of this series is to promote quality
evaluation practices within alcohol and other PSU
treatment programmes, it is helpful to define a com-
mon view of what comprises “treatment.” The term
treatment is used to define the process that begins
when PS users come into contact with a health pro-
vider or other community service, and may continue
through a succession of specific interventions until the
highest attainable level of health and well-being is
reached. Treatment and rehabilitation are defined as
Evaluation is essentially a means of getting feedback about a
programme, or a network of programmes.
Whether you view evaluation as a scientific, re-
search-oriented undertaking, or as a management
action-oriented activity, it is essentially a means of
getting feedback about a programme, or a network
of programmes. Feedback may include information
on operations, outcomes and/or cost-efficiency. There
are times when complicated strategies are required
and traditional rules of scientific methods may be
needed. This is especially true in outcome evaluation
where it is important to attribute the changes you have
measured to the programme that has been delivered.
There are other times, however, when feedback is
uncomplicated, for example, in developing a system
of documentation to record whether the people using
your programme match those you intended to serve.
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Levels of
Single case
Single case evaluation is consistent with
clinical practice in that it promotes a
problem-solving approach to planning,
implementing and evaluating interventions
tailored specifically for each client. Re-
sponsibility for getting feedback on the
progress of each client rests with the cli-
nician or therapist.
Treatment activity
The evaluation of a treatment activity in-
volves summarising the involvement of a
group of clients with a particular treatment
modality (e.g., cognitive-behavioural
therapy), and the progress they have made
collectively toward reaching their objectives.
A common approach is to identify objec-
tives that all clients participating in the treat-
ment activity share, and to use these shared
objectives to assess the progress of the
overall group.
Treatment service
The evaluation of a treatment service also
involves summarising information about a
group of clients. One treatment service (e.g.,
outpatient) can include more than one treat-
ment activity or modality (e.g., cognitive-
behavioural therapy, relapse prevention, so-
cial skills training). Because each client may
be involved with many services, the ability
to isolate the main factors contributing to
changes in the individual and the group as a
whole becomes difficult.
In the evaluation of treatment for PSU
will be working at one of the following
activity, treatment service, treatment
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Treatment agency
A treatment agency may offer more than
one type of treatment service (e.g., detoxi-
fication, inpatient, outpatient and continu-
ing care). An evaluation at the agency level
will summarise information about the in-
volvement of a group of clients with the
entire agency and their progress towards
treatment objectives. Conclusions about the
main factors contributing to positive change
across the group become difficult to make
at the agency level.
Treatment system
A community treatment system is com-
prised of many different services, agencies
and treatment settings. It involves people
evaluation
with PSU disorders and includes both
specialised and generalist services and agen-
cies. An evaluation at the treatment system
level examines the involvement of clients
with various agencies and services and
monitors their progress toward a number
of objectives. At the system level, it is ex-
tremely difficult to attribute changes in cli-
ent functioning to their involvement with any
one element of the treatment network. Evalu-
ation at this level, however, is helpful for
examining changes in system functioning
(e.g., decreased waiting periods, decreased
dropout rates after referral, improved co-
ordination and sharing of resources). As-
sumptions are then made that the improve-
ments to system functioning will translate
into improved (or equivalent) client out-
comes, but with more efficient use of sys-
tem-wide resources.
disorders, the evaluation practitioner
five levels: single case, treatment
agency,  treatment system.
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Think about treatment services in your community. Write down
different examples of treatment levels.
Treatment activity:
Treatment service:
Its your turn
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Treatment agency:
Treatment system:
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The foundation
Regardless of the type of evaluation you decide to do,
1. Decide who will be involved in the evaluation.
2. Assess your evaluation resources.
3. Describe your programme for evaluation.
4. Identify and prioritise evaluation needs
5. Define your evaluation questions.
6. Determine your evaluation measures.
7. Determine your evaluation design.
8. Ensure that your research resources are
sufficient. If not, return to Step 3.
implement your project. These steps are listed below,
PLANNING
(Workbook 1)
19Framework Workbook
WHO/MSD/MSB 00.2a
of evaluations
you will need to go through several steps to plan and
IMPLEMENTATION
(Workbook 2)
1. Prepare for data collection.
2. Collect data.
3. Analyse data.
4. Report results.
5. Make use of what was learned.
6. Start again.
and described in detail in Workbooks 1 and 2.
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As indicated in the previous pages, an important first step is to
identify and meet your partners for evaluation planning, if you
have not already done so. Depending on your situation, your
partners may include:
• Therapists or clinicians
• Programme administrators or managers
• Researchers
• Government representatives
• Patients interested in participating
All partners should be closely involved in the evaluation planning.
Each participant has unique experiences and perspectives that
can contribute to the groups knowledge base and strengthen
the overall evaluation. Other benefits include:
• Bringing multiple perspectives to the planning
• Strengthening everyones commitment to use the findings
• Adding credibility to the process
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TYPES
of evaluation
Each of these types of evaluation is de-
scribed in detail in a specialised work-
book later in the series (Workbooks 3 -
8). A brief description of each evaluation
type is provided below.
Evaluation types may have a sequential
relationship with one another. Needs as-
sessment evaluations typically happen
first and are often followed by process
and/or cost evaluations. Outcome and
economic evaluations often occur later,
after process and cost issues have been
evaluated. There are no hard and fast
rules, however, and you will need to con-
sider the special circumstances of your
setting when choosing an evaluation type.
Regardless of the type of evaluation you
choose, it is important to stay within the
limits of your resources and level of ex-
pertise (explained further in Workbook 1:
Evaluation Planning).
There are six main types of evaluation that can be planned and
implemented within a treatment service, agency or system:
• Needs assessment evaluation
• Process evaluation
• Cost evaluation
• Client satisfaction evaluation
• Outcome evaluation
• Economic evaluation
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NEEDS
assessment evaluation
(Workbook 3)
Needs assessment evaluation is a formal and systematic
attempt to determine, and then close, gaps between what
is and what should be.
about how an existing programme or com-
munity network of programmes should be
re-designed to address needs that are not
being met. The following are examples of
needs assessment questions:
• What type of treatment interventions
should a programme provide?
• How many people should be anticipated
each year in our services?
• What is the prevalence and incidence
of PSU disorders in the community?
• What are the main gaps in the commu-
nity treatment system?
• What is the projected demand for treat-
ment in the community or the region as
a whole?
Needs assessment is a formal and system-
atic attempt to determine, and then close,
gaps between “what is” and “what should
be.” It involves documenting important dis-
crepancies between current outcomes and
desired outcomes and prioritising these dis-
crepancies for programme planning and in-
tervention. In this way, needs assessment
involves both need identification and need
prioritisation.
Needs assessment is the first type of
programme evaluation. Ideally, it takes place
before the programme, or the network of
programmes, is planned and implemented.
A needs assessment addresses questions
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PROCESS
evaluation
(Workbook 4)
Process evaluation seeks to determine the extent to which the
programme is operating as planned.
the programme, and the context in which it is
operating. These are the types of questions
that are addressed in process evaluation:
• How many clients are treated each year?
• Is the type of client(s) being seen for
whom the programme or treatment sys-
tem has been designed?
• Are people having trouble accessing the
programme? How long is the waiting
list and how are people being managed
while they wait?
• Are the staff conducting client assess-
ments appropriately trained and using
“state-of-the-art” methods?
At this stage, the evaluation questions do not
ask about changes in clients that result from
services being provided. Rather the questions
concern coverage (i.e., is the programme or
system reaching all those for whom it was
intended?) and process (i.e., has the programme
or system been implemented as intended and
in an integrated manner?). Process evaluation
seeks to determine the extent to which the
programme is operating as planned.
The second type of evaluation is process
evaluation. The basic purpose of process
evaluation is to describe what is happening in
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COST
evaluation
(Workbook 5)
The third type of evaluation is cost
evaluation. The general aim of these
studies is to trace the resources used
under different circumstances. There
are three broad questions that could be
addressed. These are:
What is the cost of treating PSU disorders?
• What is the cost of treating PSU disor-
ders?
• If alternative treatment approaches are
producing equivalent outcomes, how
do these approaches compare in cost?
• What are the different costs involved
in the delivery of a service or service
system? How do changes in costs re-
late to activity levels?
Answering these types of questions involves different approaches to cost analysis, which
are explained in the workbook.
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CLIENT
The fourth type of evaluation is client satis-
faction evaluation. Measuring client satis-
faction with treatment provides valuable
feedback about the extent to which service
satisfaction evaluation
(Workbook 6)
activities have met client expectations. The
following are some of the questions that
might be asked through a client satisfac-
tion evaluation:
Measuring client satisfaction with treatment provides valuable
feedback about the extent to which service activities have
met client expectations.
• Have the services received met the
client’s expressed needs?
• Are there aspects of the services that
clients think could be improved?
• What is the perceived quality of care
from the client’s perspective?
Client satisfaction questionnaires are avail-
able for general use and are appropriate for
PSU treatment programs. Although some
are brief and user-friendly and have dem-
onstrated reliability and validity, the cross-
cultural applicability is unknown in some
instances. Other client satisfaction question-
naires can be developed to meet specific
evaluation needs.
While client satisfaction evaluation is an im-
portant part of an agency or system-level
continuous quality improvement process,
it is important to be cautious in interpreting
the results. Client satisfaction is not a sub-
stitute for measuring other, more objective
outcomes.
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OUTCOME
evaluation
(Workbook 7)
Randomised controlled trials are considered the gold standard
in the evaluation of treatment effectiveness.
treatment options (e.g., inpatient detoxifi-
cation versus ambulatory detoxification;
drug therapy or psychological therapy).
Randomised controlled trials are consid-
ered the gold standard in the evaluation of
treatment effectiveness. This is because the
design allows for inference of causality.
Another strategy that is relatively strong in its
ability to allow causal inference is the quasi-
experimental approach. Rather than randomly
assigning clients to different alternatives, the
individuals are selected in a systematic way.
Other outcome studies examine changes for
one group of clients over time. Clients are
monitored in terms of changes before and after
treatment and one can speculate about the
role of treatment in producing these changes.
A number of domains may be included when
examining outcome. They are, among others:
PSU frequency and pattern; consequences
of PSU, including dependence; psychologi-
cal functioning; physical health (including
HIV); social adjustment; family functioning;
crime and health care utilisation. While it is
not necessary to measure all domains when
evaluating a treatment approach, one should
examine more than one domain given the
broad scope of treatment objectives.
Outcome evaluation is the fifth type of evalu-
ation. An evaluation of treatment outcomes
should accomplish two things: first, measure
how clients and their circumstances have
changed and second, show that the treatment
experience has been a factor in causing this
change. The following are some questions that
might be asked in an outcome evaluation:
• Have improvements been made in the as-
pects of the person?s life that were af-
fected by PSU?
• Has there been a reduction in the fre-
quency and/or quantity of PSU?
• Are improvements related to particular
characteristics of the client and their so-
cial circumstances?
• What is the relationship between
programme or system participation and
client improvement?
There are a number of ways to design out-
come evaluation to measure change and
show that change is attributable to partici-
pation in the program. The most widely
praised strategy to measure change and in-
fer causality, is the randomised-controlled
trial. With this approach, patients are ran-
domly assigned to receive one or more
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ECONOMIC
evaluation
(Workbook 8)
Economic evaluations indicate the options that give the best
value for the resources expended.
There are three broad questions addressed
in economic evaluation:
• Is treatment worthwhile?
• Should investment (or further invest-
ment) be made in treatment A or treat-
ment B?
• Should PSU interventions be chosen
over other health or welfare interven-
tions?
The final type of evaluation is economic
evaluation. Limits to resources exist in any
community or region, and choices must be
made about resource use. Devoting re-
sources to one activity may deprive another
of the same. Economic evaluations assist
policy makers in making these types of de-
cisions. This type of evaluation involves
identifying, measuring, valuing, and com-
paring costs and outcomes of alternative
interventions. Economic evaluations indi-
cate the options that give the best value for
the resources expended.
Is treatment worthwhile?
The question is treatment worthwhile
compares the costs and consequences of
a particular treatment or system of treat-
ment against the do-nothing alternative.
If the net benefits are greater than the
costs, the policy maker would determine
that the programme is ?worthwhile? from
this monetary perspective.
Should investment (or further investment) be made in
treatment A or treatment B?
For simplicity sake, this question is ex-
pressed as a choice between two options,
but more complex choices of different pat-
terns of service provision also can be ad-
dressed. Answers to these types of ques-
tions involve comparisons across services
with similar outcomes, for example, ob-
served change in the frequency and/or quan-
tity of use of a PS. This would result in a
comparison of the costs across two
programme alternatives for achieving a given
level of outcome.
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Answering this type of question gener-
ally involves comparing programmes that
have different outcomes and different
population groups. This situation makes
evaluation of alternatives difficult since
there is unlikely to be any common unit
of outcome to be compared. Economists,
Should PSU interventions be chosen over other health or
welfare interventions?
therefore, suggest the use of an outcome
measure that reflects human well-being.
These are sometimes referred to as mea-
sures of utility? Most existing measures
have been based on changes in health and
quality of life, across different types of
health care interventions.
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Test your knowledge. Match each evaluation description with the appropriate letter.
a. needs evaluation
b. process evaluation
c. cost evaluation
d. client satisfaction evaluation
e. outcome evaluation
f. economic evaluation
A treatment agency surveys
patients about their attitudes and
feelings regarding a new evening
treatment programme.
A hospital evaluates five-year
medical costs of Ta group of
patients enrolled in a smoking
cessation programme (including the cost of
participating in the programme), compared
to another group of smokers that was not
offered the programme.
Community leaders survey
outreach workers about the kinds
of PSU-related problems that they
are seeing in the community.
A group of researchers compare a
group of patients who receive a
new kind of treatment to another
group who receive standard treatment as
usual.
A treatment agency reviews its
schedule books to determine, on
average, how long patients have to
wait before getting an assessment
appointment.
A hospital assesses the average
yearly costs of patients enrolled in
PSU treatment.
Answers: d, f, a, e, b, c
Its your turn
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Summary and
With only scarce resources for
of treatment, duplication and
All communities are faced with decisions
regarding an appropriate treatment re-
sponse for people with PSU disorders. In
the past, funding decisions were made
largely on the basis of personal experience
and opinion rather than using information
from systematic research and evaluation.
With only scarce resources for treatment,
duplication and inefficiency in the deliv-
ery of services cannot be tolerated.
This workbook series is intended to
educate programme planners, managers,
staff, and other key decision-makers
about the evaluation of PSU services
and systems. The objective of the series
is to enhance their capacity for carrying
out evaluation activities. The broader
goal of the workbooks is to enhance
treatment efficiency and cost-effective-
ness using the information that comes
from these evaluation activities.
The workbook series follows the frame-
work presented in this introductory work-
book. The first two workbooks focus on
the foundation of evaluation: planning and
implementation. The remaining work-
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conclusion
inefficiency in the delivery
services cannot be tolerated.
books (Workbooks 3 - 8) present the ba-
sic principles and practices of six
specialised types of evaluation.
It is important that the process of
planning for programme evaluation
and the implementation of various
evaluation strategies be viewed as a
learning process for programme
funders, managers, staff and other im-
portant stakeholders. Not everyone
has the same enthusiasm for evalua-
tion, especially when trade-offs must
be made between resources for
programme evaluation and resources
for direct service delivery. This intro-
ductory report, and accompanying
workbooks, are grounded in the be-
lief that the delivery of quality treat-
ment services depends critically on
feedback about emerging community
needs as well as programme opera-
tions, outcomes and costs. The mate-
rial presented in this report and the
workbooks will help meet the chal-
lenges in collecting this feedback
and using it in the decision-making
process.
